Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
US11243217B2 · kind B2 · utility
0Cited by
50References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 6, 2017 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | Jun 6, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/347
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods and compositions for identifying patients at risk of kidney injury. A risk score, which is a composite of a urinary concentration of IGFBP7 (insulin-like growth factor-binding protein 7) and a urinary concentration of TIMP-2 (tissue inhibitor of metalloproteinase 2), is determined obtained from the patient, and is used to manage patient treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.